Machine learning applications in cancer prognosis and prediction

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Polley, 2013, Statistical and practical considerations for clinical evaluation of predictive biomarkers, J Natl Cancer Inst, 105, 1677, 10.1093/jnci/djt282

Cruz, 2006, Applications of machine learning in cancer prediction and prognosis, Cancer Informat, 2, 59, 10.1177/117693510600200030

Fortunato, 2014, Assessment of circulating microRNAs in plasma of lung cancer patients, Molecules, 19, 3038, 10.3390/molecules19033038

Heneghan, 2010, MiRNAs as biomarkers and therapeutic targets in cancer, Curr Opin Pharmacol, 10, 543, 10.1016/j.coph.2010.05.010

Madhavan, 2013, Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures, Front Genet, 4, 10.3389/fgene.2013.00116

Zen, 2012, Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers, Med Res Rev, 32, 326, 10.1002/med.20215

Koscielny, 2010, Why most gene expression signatures of tumors have not been useful in the clinic, Sci Transl Med, 2, 10.1126/scitranslmed.3000313

Michiels, 2005, Prediction of cancer outcome with microarrays: a multiple random validation strategy, Lancet, 365, 488, 10.1016/S0140-6736(05)17866-0

Bishop, 2006

Mitchell, 2006

Witten, 2005

Niknejad, 2013, Introduction to computational intelligence techniques and areas of their applications in medicine, Med Appl Artif Intell, 51, 10.1201/b15618-5

Pang-Ning, 2006

Drier, 2011, Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?, PLoS One, 6, e17795, 10.1371/journal.pone.0017795

Dupuy, 2007, Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting, J Natl Cancer Inst, 99, 147, 10.1093/jnci/djk018

Ein-Dor, 2005, Outcome signature genes in breast cancer: is there a unique set?, Bioinformatics, 21, 171, 10.1093/bioinformatics/bth469

Ein-Dor, 2006, Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer, Proc Natl Acad Sci, 103, 5923, 10.1073/pnas.0601231103

Ayer, 2010, Breast cancer risk estimation with artificial neural networks revisited, Cancer, 116, 3310, 10.1002/cncr.25081

Platt, 1999, 547

Adams, 2012

Cicchetti, 1992, Neural networks and diagnosis in the clinical laboratory: state of the art, Clin Chem, 38, 9, 10.1093/clinchem/38.1.9

Cochran, 1997, Prediction of outcome for patients with cutaneous melanoma, Pigment Cell Res, 10, 162, 10.1111/j.1600-0749.1997.tb00479.x

Exarchos, 2012, Multiparametric decision support system for the prediction of oral cancer reoccurrence, IEEE Trans Inf Technol Biomed, 16, 1127, 10.1109/TITB.2011.2165076

Kononenko, 2001, Machine learning for medical diagnosis: history, state of the art and perspective, Artif Intell Med, 23, 89, 10.1016/S0933-3657(01)00077-X

Park, 2013, Robust predictive model for evaluating breast cancer survivability, Engl Appl Artif Intell, 26, 2194, 10.1016/j.engappai.2013.06.013

Sun, 2007, Improved breast cancer prognosis through the combination of clinical and genetic markers, Bioinformatics, 23, 30, 10.1093/bioinformatics/btl543

Bottaci, 1997, Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions, Lancet, 350, 469, 10.1016/S0140-6736(96)11196-X

Maclin, 1991, Using neural networks to diagnose cancer, J Med Syst, 15, 11, 10.1007/BF00993877

Simes, 1985, Treatment selection for cancer patients: application of statistical decision theory to the treatment of advanced ovarian cancer, J Chronic Dis, 38, 171, 10.1016/0021-9681(85)90090-6

Akay, 2009, Support vector machines combined with feature selection for breast cancer diagnosis, Expert Syst Appl, 36, 3240, 10.1016/j.eswa.2008.01.009

Chang, 2013, Oral cancer prognosis based on clinicopathologic and genomic markers using a hybrid of feature selection and machine learning methods, BMC Bioinforma, 14, 170, 10.1186/1471-2105-14-170

Chuang, 2011, 16

Eshlaghy, 2013, Using three machine learning techniques for predicting breast cancer recurrence, J Health Med Inform, 4, 124

Exarchos, 2012, A multiscale and multiparametric approach for modeling the progression of oral cancer, BMC Med Inform Decis Mak, 12, 136, 10.1186/1472-6947-12-136

Kim, 2013, Breast cancer survivability prediction using labeled, unlabeled, and pseudo-labeled patient data, J Am Med Inform Assoc, 20, 613, 10.1136/amiajnl-2012-001570

Fielding, 1992, The future of prognostic factors in outcome prediction for patients with cancer, Cancer, 70, 2367, 10.1002/1097-0142(19921101)70:9<2367::AID-CNCR2820700927>3.0.CO;2-B

Bach, 2003, Variations in lung cancer risk among smokers, J Natl Cancer Inst, 95, 470, 10.1093/jnci/95.6.470

Domchek, 2003, Application of breast cancer risk prediction models in clinical practice, J Clin Oncol, 21, 593, 10.1200/JCO.2003.07.007

Gascon, 2004, Childhood obesity and hormonal abnormalities associated with cancer risk, Eur J Cancer Prev, 13, 193, 10.1097/01.cej.0000130021.16182.c3

Ren, 2013, ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions, Nucleic Acids Res, 41, e53, 10.1093/nar/gks1288

Ren, 2013, iPcc: a novel feature extraction method for accurate disease class discovery and prediction, Nucleic Acids Res, gkt343

Wang, 2012, Revealing metabolite biomarkers for acupuncture treatment by linear programming based feature selection, BMC Syst Biol, 6, S15, 10.1186/1752-0509-6-S1-S15

Waddell, 2005, Predicting cancer susceptibility from single-nucleotide polymorphism data: a case study in multiple myeloma, ACM, 21

Listgarten, 2004, Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms, Clin Cancer Res, 10, 2725, 10.1158/1078-0432.CCR-1115-03

Stojadinovic, 2011, Development of a Bayesian belief network model for personalized prognostic risk assessment in colon carcinomatosis, Am Surg, 77, 221, 10.1177/000313481107700225

Kim, 2012, Development of novel breast cancer recurrence prediction model using support vector machine, J Breast Cancer, 15, 230, 10.4048/jbc.2012.15.2.230

Park, 2014, Integrative gene network construction to analyze cancer recurrence using semi-supervised learning, PLoS One, 9, e86309, 10.1371/journal.pone.0086309

Tseng, 2014, Application of machine learning to predict the recurrence-proneness for cervical cancer, Neural Comput & Applic, 24, 1311, 10.1007/s00521-013-1359-1

Chen, 2014, Risk classification of cancer survival using ANN with gene expression data from multiple laboratories, Comput Biol Med, 48, 1, 10.1016/j.compbiomed.2014.02.006

Xu, 2012, A gene signature for breast cancer prognosis using support vector machine, IEEE, 928

Gevaert, 2006, Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks, Bioinformatics, 22, e184, 10.1093/bioinformatics/btl230

Rosado, 2013, Survival model in oral squamous cell carcinoma based on clinicopathological parameters, molecular markers and support vector machines, Expert Syst Appl, 40, 4770, 10.1016/j.eswa.2013.02.032

Delen, 2005, Predicting breast cancer survivability: a comparison of three data mining methods, Artif Intell Med, 34, 113, 10.1016/j.artmed.2004.07.002

Urbanowicz, 2013, Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach, J Am Med Inform Assoc, 20, 603, 10.1136/amiajnl-2012-001574

Bochare, 2014, Integrating domain knowledge in supervised machine learning to assess the risk of breast cancer, Int J Med Eng Inform, 6, 87, 10.1504/IJMEI.2014.060245

Gilmore, 2010, A support vector machine for decision support in melanoma recognition, Exp Dermatol, 19, 830, 10.1111/j.1600-0625.2010.01112.x

Mac Parthaláin, 2010

Hall, 1999

Kohavi, 1997, Wrappers for feature subset selection, Artif Intell, 97, 273, 10.1016/S0004-3702(97)00043-X

Estévez, 2009, Normalized mutual information feature selection, IEEE Trans Neural Netw, 20, 189, 10.1109/TNN.2008.2005601

Barrett, 2007, NCBI GEO: mining tens of millions of expression profiles — database and tools update, Nucleic Acids Res, 35, D760, 10.1093/nar/gkl887

Niu, 2010, Evaluation of linguistic features useful in extraction of interactions from PubMed; application to annotating known, high-throughput and predicted interactions in I2D, Bioinformatics, 26, 111, 10.1093/bioinformatics/btp602

Howlader, 2013

Bian, 2009

Papadopoulos, 2008, Improvement of microcalcification cluster detection in mammography utilizing image enhancement techniques, Comput Biol Med, 38, 1045, 10.1016/j.compbiomed.2008.07.006

Papadopoulos, 2005, Characterization of clustered microcalcifications in digitized mammograms using neural networks and support vector machines, Artif Intell Med, 34, 141, 10.1016/j.artmed.2004.10.001

Bilal, 2013, Improving breast cancer survival analysis through competition-based multidimensional modeling, PLoS Comput Biol, 9, e1003047, 10.1371/journal.pcbi.1003047

Cuzick, 2011, Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer, J Clin Oncol, 29, 4273, 10.1200/JCO.2010.31.2835

Parker, 2009, Supervised risk predictor of breast cancer based on intrinsic subtypes, J Clin Oncol, 27, 1160, 10.1200/JCO.2008.18.1370

Paik, 2004, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med, 351, 2817, 10.1056/NEJMoa041588